UQ researchers are buoyed by investment in promising heart attack treatment. (Left to right, Associate Professor Nathan Palpant, Associate Professor Mark Smythe and Professor Glenn King). Supplied.

A potentially life-saving treatment containing venom from one of the world’s deadliest spiders is one step closer to human trials, thanks to a $23 million investment in a Brisbane startup.

4 July 2022